10-Q Filing

Company

Travere Therapeutics, Inc.

Filed

September 16, 2013

Period of Report

June 30, 2013

Accession Number

0001193805-13-001602

A 10-Q is a quarterly financial report filed after each of the first three quarters of a fiscal year. It includes unaudited financial statements and management commentary. Learn more about 10-Q filings →